tradmap

GOSS Earnings Gossamer Bio, Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing

Annual results

Diluted EPS (annual)
-$284 -$142 $0 2019 2020 2021 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $57M $115M 2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$243M -$122M $0 2017 2018 2019 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$17 $0 $18 $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
EPS
Revenue (quarterly)
$0 $48M $96M Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Revenue
Net income (quarterly)
-$48M $505500 $49M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income

Reported EPS history

1–33 of 33
Q2 20262026-06-30-6.402026-08-1310-Q
Q1 20262026-03-31-16.002026-05-1510-Q
Q4 2025 (derived)2025-12-31-16.802026-03-1710-K
FY 20252025-12-31-60.002026-03-1710-K
Q3 20252025-09-30-16.802025-11-0510-Q
Q2 20252025-06-30-13.602025-08-0510-Q
Q1 20252025-03-31-12.802025-05-1510-Q
Q4 2024 (derived)2024-12-31-11.202025-03-1310-K
FY 20242024-12-31-20.002025-03-1310-K
Q3 20242024-09-30-11.202024-11-0710-Q
Q2 20242024-06-3017.602024-08-1210-Q
Q1 20242024-03-31-15.202024-05-0710-Q
Q4 2023 (derived)2023-12-310.002024-03-0510-K
FY 20232023-12-31-94.402024-03-0510-K
Q3 20232023-09-30-16.802023-11-0910-Q
Q2 20232023-06-30-36.002023-08-0810-Q
Q1 20232023-03-31-41.602023-05-0910-Q
Q4 2022 (derived)2022-12-31-44.802023-03-1710-K
FY 20222022-12-31-216.802023-03-1710-K
Q3 20222022-09-30-52.002022-11-0310-Q
Q2 20222022-06-30-59.202022-08-0910-Q
Q1 20222022-03-31-60.802022-05-1010-Q
Q4 2021 (derived)2021-12-31-60.002022-03-0310-K
FY 20212021-12-31-250.402022-03-0310-K
Q3 20212021-09-30-64.002021-11-0810-Q
Q2 20212021-06-30-64.002021-08-0910-Q
Q1 20212021-03-31-62.402021-05-0610-Q
Q4 2020 (derived)2020-12-31-70.40——
FY 20202020-12-31-284.00——
Q3 20202020-09-30-64.00——
Q2 20202020-06-30-80.00——
Q1 20202020-03-31-69.60——
FY 20192019-12-31-263.20——

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.